The Histone Deacetylase Inhibitor, Vorinostat, Reduces Tumor Growth at the Metastatic Bone Site and Associated Osteolysis, but Promotes Normal Bone Loss

Normal Bone ◽

Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-15-2260 ◽

2016 ◽

Vol 22 (14) ◽

pp. 3560-3570 ◽

Cited By ~ 23

Author(s):

Andrea Muscat ◽

Dean Popovski ◽

W. Samantha N. Jayasekara ◽

Fernando J. Rossello ◽

Melissa Ferguson ◽

...

Keyword(s):

Tumor Growth ◽

Histone Deacetylase ◽

Low Dose ◽

Growth Arrest ◽

Lineage Differentiation ◽

Deacetylase Inhibitor ◽

Rhabdoid Tumors ◽

Inhibitor Treatment

Abstract 4741: Targeting tumor growth in a medullary thyroid carcinoma mouse model using a combinatorial treatment with a tyrosine kinase inhibitor and histone deacetylase inhibitor

10.1158/1538-7445.am2016-4741 ◽

2016 ◽

Cited By ~ 1

Author(s):

Karine Pozo ◽

Stefan Zahler ◽

Chunfeng Tan ◽

Keisuke Ishimatsu ◽

Masaya Takahashi ◽

...

Keyword(s):

Mouse Model ◽

Thyroid Carcinoma ◽

Tumor Growth ◽

Tyrosine Kinase Inhibitor ◽

Histone Deacetylase ◽

Kinase Inhibitor ◽

Medullary Thyroid ◽

Deacetylase Inhibitor ◽

Combinatorial Treatment

Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42

Neoplasia ◽

10.1016/j.neo.2016.10.003 ◽

2016 ◽

Vol 18 (12) ◽

pp. 765-774 ◽

Cited By ~ 12

Author(s):

Sally E. Henderson ◽

Li-Yun Ding ◽

Xiaokui Mo ◽

Tanios Bekaii-Saab ◽

Samuel K. Kulp ◽

...

Keyword(s):

Pancreatic Cancer ◽

Mouse Model ◽

Tumor Growth ◽

Transgenic Mouse ◽

Histone Deacetylase ◽

Muscle Wasting ◽

Transgenic Mouse Model ◽

The Novel ◽

Inhibition of osteoclastogenesis by histone deacetylase inhibitor Quisinostat protects mice against titanium particle-induced bone loss

European Journal of Pharmacology ◽

10.1016/j.ejphar.2021.174176 ◽

2021 ◽

pp. 174176

Author(s):

Liwei Zhang ◽

Lei Zhang ◽

Hongji You ◽

Shengxuan Sun ◽

Zirui Liao ◽

...

Keyword(s):

Bone Loss ◽

Histone Deacetylase ◽

Titanium Particle ◽

UP-3.008: Inhibition of Bladder Tumor Growth by Histone Deacetylase Inhibitor

Urology ◽

10.1016/j.urology.2009.07.011 ◽

2009 ◽

Vol 74 (4) ◽

pp. S297

Author(s):

A. Ozawa ◽

N. Tanji ◽

T. Kikugawa ◽

T. Sasaki ◽

Y. Yanagihara ◽

...

Keyword(s):

Tumor Growth ◽

Histone Deacetylase ◽

Bladder Tumor ◽

Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo

Cancer Letters ◽

10.1016/s0304-3835(03)00184-8 ◽

2003 ◽

Vol 195 (2) ◽

pp. 161-168 ◽

Cited By ~ 29

Author(s):

Yuka Sasakawa ◽

Yoshinori Naoe ◽

Takeshi Inoue ◽

Tatsuya Sasakawa ◽

Masahiko Matsuo ◽

...

Keyword(s):

Tumor Growth ◽

Histone Deacetylase ◽

Non-viral delivery of the connexin 43 gene with histone deacetylase inhibitor to human nasopharyngeal tumor cells enhances gene expression and inhibits in vivo tumor growth

International Journal of Oncology ◽

10.3892/ijo.30.6.1427 ◽

2007 ◽

Cited By ~ 2

Author(s):

Yoshiyuki Hattori ◽

Masayoshi Fukushima ◽

Yoshie Maitani

Keyword(s):

Gene Expression ◽

Tumor Growth ◽

Tumor Cells ◽

Histone Deacetylase ◽

Connexin 43 ◽

Nasopharyngeal Tumor ◽

MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice

European Journal of Pharmacology ◽

10.1016/j.ejphar.2012.07.034 ◽

2012 ◽

Vol 691 (1-3) ◽

pp. 69-76 ◽

Cited By ~ 13

Author(s):

Ha-Neui Kim ◽

Jong-Ho Lee ◽

Won Jong Jin ◽

Sungjin Ko ◽

Kyoungsuk Jung ◽

...

Keyword(s):

Bone Loss ◽

Histone Deacetylase ◽

Deacetylase Inhibitor ◽

Fos Expression

147: Low Concentration of a Histone Deacetylase Inhibitor, Depsipeptide (FK228), Enhances the Effect of Gemcitabine and Docetaxel in Hormone Refractory Prostate Cancer Cells

The Journal of Urology ◽

10.1016/s0022-5347(18)30412-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 50-51

Author(s):

Masatoshi Kanzaki ◽

Hideaki Kakinuma ◽

Teruaki Kumazawa ◽

Takamitsu Inoue ◽

Mitsuru Saito ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Hormone Refractory Prostate Cancer ◽

Prostate Cancer Cells ◽

Low Concentration ◽

Deacetylase Inhibitor ◽

Hormone Refractory

Structure-activity investigations of Santacruzamate A, a potent histone deacetylase inhibitor isolated from a Panamanian cyanobacterium

Planta Medica ◽

10.1055/s-0032-1320383 ◽

2012 ◽

Vol 78 (11) ◽

Author(s):

CM Pavlik ◽

MJ Balunas

Keyword(s):

Histone Deacetylase ◽

Structure Activity ◽